Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 31
Phase 42

Trial Status

Completed4
Other1

Role Distribution

Principal Investigator5
PI Rate100%

Activity Timeline

Clinical Trials (5)

NCT03093818Not ApplicableCompleted
PREemptive Pharmacogenomic Testing for Preventing Adverse Drug REactions
Adverse Drug Reaction
PrincipalinvestigatorStart date: 2017-03-20
NCT02198495Phase 4Completed
Comparison Study of Two Iron Compounds for Treatment of Anemia in Hemodialysis Patients
Anemia of Chronic Kidney Disease
PrincipalinvestigatorStart date: 2014-09-01
NCT03751332Phase 4Completed
The Vienna Prograf and Endothelial Progenitor Cell Extension Study
ImmunosuppressionRenal Failure
PrincipalinvestigatorStart date: 2008-03-01
NCT01632605Not ApplicableCompleted
The Vienna RAP Pilot Study
ADPKD
Principalinvestigator
NCT02055079Phase 3Unknown
Pulsed Oral Sirolimus in Autosomal Dominant Polycystic Kidney Disease
Polycystic Kidney, Type 1 Autosomal Dominant DiseasePolycystic Kidney, Type 2 Autosomal Dominant Disease
Principalinvestigator

Research Network

Collaboration Network

8 collaborators·22 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Markus Riegersperger, MD

Medical University of Vienna

Related
1 trials

Shared therapeutic areas:

Polycystic Kidney, Type 1 Autosomal Dominant DiseasePolycystic Kidney, Type 2 Autosomal Dominant Disease

Worked with same sponsors:

Medical University of Vienna
Collaborated on 1 trial
Similarity Score24%

Vita Dolzan, MD PhD

University of Ljubljana

Related
1 trials

Shared therapeutic areas:

Drug-Related Side Effects and Adverse Reactions

Worked with same sponsors:

Andaluz Health ServiceBio.Logis Genetic Information Management+14 more
Collaborated on 1 trial
Similarity Score14%

Cristina Lucía Dávila Fajardo, PharmD PhD

Andaluz Health Service

Related
1 trials

Shared therapeutic areas:

Drug-Related Side Effects and Adverse Reactions

Worked with same sponsors:

Andaluz Health ServiceBio.Logis Genetic Information Management+14 more
Collaborated on 1 trial
Similarity Score14%

George P. Patrinos, PhD

University of Patras

Related
1 trials

Shared therapeutic areas:

Drug-Related Side Effects and Adverse Reactions

Worked with same sponsors:

Andaluz Health ServiceBio.Logis Genetic Information Management+14 more
Collaborated on 1 trial
Similarity Score14%

Munir Pirmohamed, MB ChB(Hons) PhD

University of Liverpool

Related
1 trials

Shared therapeutic areas:

Drug-Related Side Effects and Adverse Reactions

Worked with same sponsors:

Andaluz Health ServiceBio.Logis Genetic Information Management+14 more
Collaborated on 1 trial
Similarity Score14%

Jesse J. Swen, PharmD PhD

Leiden University Medical Center

Related
1 trials

Shared therapeutic areas:

Drug-Related Side Effects and Adverse Reactions

Worked with same sponsors:

Andaluz Health ServiceBio.Logis Genetic Information Management+14 more
Collaborated on 1 trial
Similarity Score14%

Giuseppe Toffoli, MD

Centro di Riferimento Oncologico

Related
1 trials

Shared therapeutic areas:

Drug-Related Side Effects and Adverse Reactions

Worked with same sponsors:

Andaluz Health ServiceBio.Logis Genetic Information Management+14 more
Collaborated on 1 trial
Similarity Score14%

Raymond Vanholder, MD, PhD

University Hospital, Ghent

Related
12 trials

Shared therapeutic areas:

Kidney Failure
Similarity Score4%

Yves Donazzolo, MD

Eurofins Optimed

Related
8 trials

Shared therapeutic areas:

Kidney Failure
Similarity Score4%

A. John Barrett, M.D.

National Heart, Lung, and Blood Institute (NHLBI)

Related
7 trials

Shared therapeutic areas:

Immunosuppression Therapy
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT03093818Not ApplicablePrincipalInvestigator

PREemptive Pharmacogenomic Testing for Preventing Adverse Drug REactions

Adverse Drug Reaction
Completed
NCT02198495Phase 4PrincipalInvestigator

Comparison Study of Two Iron Compounds for Treatment of Anemia in Hemodialysis Patients

Anemia of Chronic Kidney Disease
Completed
NCT03751332Phase 4PrincipalInvestigator

The Vienna Prograf and Endothelial Progenitor Cell Extension Study

ImmunosuppressionRenal Failure
Completed
NCT01632605Not ApplicablePrincipalInvestigator

The Vienna RAP Pilot Study

ADPKD
Completed
NCT02055079Phase 3PrincipalInvestigator

Pulsed Oral Sirolimus in Autosomal Dominant Polycystic Kidney Disease

Polycystic Kidney, Type 1 Autosomal Dominant DiseasePolycystic Kidney, Type 2 Autosomal Dominant Disease
Unknown

All 5 trials loaded